More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia

Guillermo Montalban-Bravo, Christopher B. Benton, Sa A. Wang, Farhad Ravandi, Tapan Kadia, Jorge Cortes, Naval Daver, Koichi Takahashi, Courtney Dinardo, Elias Jabbour, Gautam Borthakur, Marina Konopleva, Sherry Pierce, Carlos Bueso-Ramos, Keyur Patel, Steven Kornblau, Hagop Kantarjian, Ken H. Young, Guillermo Garcia-Manero, Michael Andreeff

Research output: Contribution to journalLetter

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)2584-2587
Number of pages4
JournalBlood
Volume129
Issue number18
DOIs
StatePublished - May 4 2017
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Montalban-Bravo, G., Benton, C. B., Wang, S. A., Ravandi, F., Kadia, T., Cortes, J., Daver, N., Takahashi, K., Dinardo, C., Jabbour, E., Borthakur, G., Konopleva, M., Pierce, S., Bueso-Ramos, C., Patel, K., Kornblau, S., Kantarjian, H., Young, K. H., Garcia-Manero, G., & Andreeff, M. (2017). More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia. Blood, 129(18), 2584-2587. https://doi.org/10.1182/blood-2016-11-749903